Collectively, our results reveal that midazolam ameliorates hyperglycemia-induced glomerular endothelial dysfunction and renal fibrosis by inhibiting hyperglycemia-induced intracellular Ca2+ elevation and subsequent ROS generation and TGase2 activation in kidneys of diabetic mice (Figure 8e). This evidence concerns the gene TGM2 and renal fibrosis.